Table: Sapporo Clinical Lab -Q1 group results

Sapporo Clinical Laboratory

06/08/2021 07:30

Aug 6 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2021        Jun 30, 2020     Mar 31, 2022 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             4.64                4.07             17.41    
                 (+13.9 pct)         (-8.0 pct)       (-0.5 pct)  
  Operating        292 mln             33 mln           855 mln   
                (+762.5 pct)         (-87.3 pct)      (-25.1 pct) 
  Recurring        293 mln             39 mln           957 mln   
                (+638.0 pct)         (-85.4 pct)      (-19.4 pct) 
  Net              107 mln           loss 1 mln         574 mln   
                                                      (-27.7 pct) 
  EPS             31.31 yen         loss 0.39 yen     167.73 yen  
  Ann Div                             23.00 yen        23.00 yen  
  -Q2 div                                NIL              NIL     
  -Q4 div                             23.00 yen        23.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T